These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8672984)

  • 1. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents.
    Greenwald P; Kelloff GJ; Boone CW; McDonald SS
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):691-702. PubMed ID: 8672984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis.
    Williams AC; Browne SJ; Manning AM; Hague A; van der Stappen JW; Paraskeva C
    Semin Cancer Biol; 1993 Jun; 4(3):153-9. PubMed ID: 8318691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
    Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
    J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic considerations in the evaluation of chemopreventive data.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
    IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of colorectal cancer.
    Gwyn K; Sinicrope FA
    Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
    Couturier D
    Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
    Jalving M; Koornstra JJ; De Jong S; De Vries EG; Kleibeuker JH
    Aliment Pharmacol Ther; 2005 Feb; 21(4):321-39. PubMed ID: 15709983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New rodent models for studies of chemopreventive agents.
    Lipkin M
    J Cell Biochem Suppl; 1997; 28-29():144-7. PubMed ID: 9589360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
    Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
    Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia.
    Rigas B
    Curr Opin Gastroenterol; 2007 Jan; 23(1):55-9. PubMed ID: 17133086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional factors and polyamine metabolism in colorectal cancer.
    Linsalata M; Russo F
    Nutrition; 2008 Apr; 24(4):382-9. PubMed ID: 18262757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in colorectal cancer.
    Owen RW
    IARC Sci Publ; 2001; 154():101-11. PubMed ID: 11220650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of apoptosis and the prevention of colorectal cancer.
    Watson AJ
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):107-21. PubMed ID: 16326109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.
    Fenton JI; Hord NG
    Carcinogenesis; 2006 May; 27(5):893-902. PubMed ID: 16474168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
    Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway.
    Patel R; Ingle A; Maru GB
    Toxicol Appl Pharmacol; 2008 Feb; 227(1):136-46. PubMed ID: 18037152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.